Study finds Liverpool Care Pathway may not improve care, survival

A randomized clinical trial of Italian cancer patients in 16 hospital wards showed those treated using the end-of-life Liverpool Care Pathway did not have better survival times or significantly improved care compared with patients who received standard care. Use of the LCP is being phased out in the U.K., and study co-author Irene Higginson said the data show it will be important for future programs to be "grounded in scientific evidence and tested in controlled trials before being rolled out across the board."

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA